Quantcast

Latest Microarrays Stories

2014-07-09 08:33:53

DUBLIN, July 9, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/nghblz/analysis_of) has announced the addition of the "Analysis of Global Biochips Industry, 2012-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Global biochips market is forecasted to reach US$11.4 billion by 2018 with a CAGR of 18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific followed by the European Union. Among the major...

2014-06-20 12:23:10

DUBLIN, June 20, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/vcmqj4/gene_expression) has announced the addition of the "Global Gene Expression (DNA Microarray, Real-Time PCR, Next Generation Sequencing) Analysis Market - Forecast to 2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various...

2014-06-19 08:28:14

SOPHIA ANTIPOLIS, France, and SAN DIEGO, June 19, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, and Sequenom, Inc. (NASDAQ:SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that Nicox's subsidiary, Nicox Inc. is launching expanded access to Sequenom Laboratories' RetnaGene(TM) portfolio of laboratory-developed genetic tests in the United States (U.S.). The RetnaGene portfolio includes...

2014-06-18 23:06:59

$3 Million NIH Grant to Fund Effort to Rescue Tissue That Would be Destroyed Charlottesville, Va. (PRWEB) June 18, 2014 The University of Virginia Health System has been awarded more than $3 million from the National Institutes of Health’s National Cancer Institute to support and expand a critically important program that makes tissue samples available for research on diseases ranging from breast cancer to lung disease. The five-year grant enables UVA to launch a partnership with...

2014-06-16 08:28:27

SAN DIEGO, June 16, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, announced today that it has received premarket 510(k) clearance from the United States Food and Drug Administration (FDA) to market its IMPACT Dx(TM) Factor V Leiden and Factor II Genotyping Test and the IMPACT Dx(TM) System. The IMPACT Dx Factor V Leiden and Factor II Genotyping Test is performed on the IMPACT Dx System, and is indicated...

2014-06-16 08:28:21

MADISON, N.J. and SAN DIEGO, June 16, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, and Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced an agreement under which Quest will offer national access to Sequenom Laboratories' MaterniT21(TM) PLUS laboratory-developed test (LDT). Using a maternal blood sample, the noninvasive prenatal test (NIPT)...

2014-06-16 04:21:39

IMPACT Dx(TM) Combined Function System Will Also Be Available in the European Union SAN DIEGO, June 16, 2014 /PRNewswire/ -- Agena Bioscience, Inc., which recently acquired the Bioscience business of Sequenom, Inc., was notified today by Sequenom, Inc. that it received premarket clearance from the U.S. Food and Drug Administration (FDA) for the IMPACT Dx(TM) Factor V Leiden and Factor II Genotyping Test and the IMPACT Dx(TM) System. The IMPACT Dx(TM) Factor V Leiden and Factor II...

2014-06-12 23:05:29

The newly released Pre-Sure ChIP Antibody Validation Kit is a fast, affordable, and robust method for ChIP-grade validation of antibodies for use in ChIP-PCR, ChIP-on-chip, and ChIP-seq. Farmingdale, NY (PRWEB) June 12, 2014 Epigentek today announced the debut of Pre-Sure(TM), a commercialized kit for quickly validating and qualifying whether antibodies are suitable for use in chromatin immunoprecipitation (ChIP). Officially known as the Pre-Sure(TM) ChIP Antibody Validation Kit, the...

2014-06-09 08:28:20

Large amounts of information generated by gene expression profiling will increase implementation of data management tools LONDON, June 9, 2014 /PRNewswire/ -- Gene expression profiling can bring significant improvements to disease profiling and diagnoses based on genetic disposition. Recent technology advances in this area are in fact enabling personalized medicine, where physicians provide patients with tailor-made treatment plans to fight diseases. Cases of cancer, cardiovascular...

2014-06-09 08:28:07

SAN DIEGO, June 9, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, has signed a national agreement with a leading health insurance company covering 13 million people throughout the United States, to provide the MaterniT21(TM) PLUS laboratory-developed test (LDT). The addition of this contract brings the number of covered lives...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.